Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Integrated transcriptomics, network pharmacology and clinical expression validation reveal the prognostic significance of PANoptosis-related genes in cordycepin-treated lung adenocarcinoma
Saved in:
| Published in: | Discover Oncology |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Integrated transcriptomics, network pharmacology and clinical expression validation reveal the prognostic significance of PANoptosis-related genes in cordycepin-treated lung adenocarcinoma
- Proteomic stratification reveals immune metabolic heterogeneity in lung adenocarcinoma
- Hypomethylation of in lung adenocarcinoma mirrors an epigenetic signature of airway cell differentiation states
- GFPT2 upregulation predicts poor prognosis and is associated with TGF-β/Smad activation in lung adenocarcinoma
- Fascin-1 expression in non-small cell lung cancer and its diagnostic implications
- Correction to “Rapid and Significant Reduction in Size of Pituitary Adenoma in Children Treated with Fractionated Stereotactic Radiation Therapy: A Case Report”
- Peripheral blood IFN-γ–producing T-cell subsets and soluble IL-2 receptor as independent prognostic biomarkers in NSCLC treated with immune checkpoint inhibitor–based therapy